FDA Approved: LATANOPROST — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a generic latanoprost product from Rising Pharma Holdings, Inc. via an Original Application (ANDA 202442) to reduce intraocular pressure in ope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

ORIG AP for LATANOPROST (LATANOPROST)